AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) has received approval from the US Food and Drug Administration (FDA) for an expanded indication of ...
Donald Trump’s AI tsar has claimed there is “substantial evidence” that China’s low-cost chatbot DeepSeek copied some of the technology developed by US rival OpenAI, the creator of ChatGPT.
British chip designer Arm Holdings Plc’s ARM Chinese venture is eyeing Chen Feng, a former Rockchip Electronics Co. officer, as its CEO, taking over from co-CEOs Liu Renchen and Eric Chen. The ...